Leptospirosis in Dogs: Diagnosis, Treatment, and Prevention
Introduction
Leptospirosis is a globally distributed bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira. In dogs, infection can result in acute kidney injury, hepatic dysfunction, pulmonary hemorrhage, and uveitis. The disease is maintained in nature through chronic renal carriage in reservoir hosts, including rodents, wildlife, and domestic animals. Dogs serve as both accidental hosts and potential sentinels for environmental contamination. The clinical presentation is highly variable, ranging from subclinical infection to fulminant multi-organ failure, making accurate diagnosis and timely intervention critical. This article provides a detailed review of the bacteriology, pathogenesis, diagnostic modalities, therapeutic protocols, and preventive strategies for canine leptospirosis, with emphasis on serological and molecular methods.
Bacteriology and Pathogenesis
Leptospira are Gram-negative, aerobic, motile spirochetes belonging to the phylum Spirochaetes. Pathogenic species include L. interrogans, L. kirschneri, L. borgpetersenii, and L. noguchii, among others. Serovar classification is based on lipopolysaccharide (LPS) antigenic diversity; over 250 serovars have been described. Common serovars associated with canine disease include Canicola, Icterohaemorrhagiae, Grippotyphosa, Pomona, and Australis [3, 9, 13]. Genomic comparisons have revealed that L. interrogans isolates from dogs, humans, and wildlife share high sequence identity, supporting the role of dogs as bridging hosts in multi-host transmission cycles [10].
Pathogenesis begins with penetration of mucous membranes or abraded skin. The spirochetes disseminate hematogenously and colonize the proximal renal tubules, liver parenchyma, and pulmonary endothelium. Renal colonization leads to interstitial nephritis and tubular necrosis. Hepatic involvement causes cholestasis and hepatocellular injury. Pulmonary hemorrhage results from endothelial damage and vasculitis. Serial evaluation of pulmonary function in experimentally infected dogs has demonstrated progressive decreases in arterial oxygen tension and increases in bronchoalveolar lavage fluid protein content, correlating with histopathological evidence of alveolar hemorrhage [1].
Clinical Signs and Clinicopathological Abnormalities
The incubation period ranges from 5 to 14 days. Clinical signs are non-specific and may include fever, lethargy, vomiting, diarrhea, polyuria, polydipsia, icterus, and abdominal pain. Acute kidney injury is the most common manifestation, with azotemia, isosthenuria, and proteinuria. Hepatic involvement is characterized by elevated liver enzyme activities and hyperbilirubinemia. Pulmonary leptospirosis presents with tachypnea, dyspnea, and hemoptysis; thoracic radiography may reveal diffuse interstitial to alveolar patterns.
Clinicopathological findings include thrombocytopenia, leukocytosis, and elevated acute-phase proteins. Serum sialic acid concentrations have been investigated as a biomarker of inflammation and infection in dogs with leptospirosis, showing significant elevation compared to healthy controls [4]. Coagulation abnormalities, including prolonged prothrombin time and activated partial thromboplastin time, may be present in severe cases.
Diagnostic Approaches
Accurate diagnosis relies on a combination of serology, molecular detection, and culture. The following sections detail the principal diagnostic methods.
Serology: Microscopic Agglutination Test (MAT)
The microscopic agglutination test (MAT) is the reference standard for serodiagnosis. It detects antibodies against a panel of live leptospiral serovars. A single MAT titer of 1:800 or greater in a dog with compatible clinical signs is considered indicative of active infection. A four-fold rise in titer between paired acute and convalescent sera (collected 2 to 4 weeks apart) confirms recent infection. However, MAT has limitations: it requires maintenance of live cultures, is labor-intensive, and may yield false-negative results in early infection or in dogs infected with serovars not included in the panel. Cross-reactivity among serovars complicates serovar-specific interpretation [7, 15].
Enzyme-Linked Immunosorbent Assay (ELISA)
Commercial ELISA kits targeting Leptospira-specific IgM and IgG antibodies offer higher throughput and do not require live organisms. IgM detection is useful for identifying acute infection, while IgG indicates prior exposure or vaccination. The sensitivity and specificity of ELISA vary depending on the antigen used. Recombinant antigen-based assays, such as those employing Loa22, have been developed to improve diagnostic accuracy. A lateral flow assay incorporating Loa22 conjugated to gold nanoparticles demonstrated promising sensitivity and specificity for serodiagnosis in canine and bovine samples [12].
Molecular Diagnostics: Polymerase Chain Reaction (PCR)
PCR assays targeting conserved genes such as lipL32, secY, or 16S rRNA enable direct detection of leptospiral DNA in blood, urine, or tissue samples. Real-time PCR (qPCR) provides quantitative results and is more sensitive than conventional PCR. Blood PCR is most sensitive during the leptospiremic phase (first 7 to 10 days of illness), while urine PCR is preferred after the first week when renal shedding begins. False-negative results can occur due to intermittent shedding or low bacterial load. Multiplex PCR panels that differentiate pathogenic from saprophytic species are available [3, 9, 11].
Culture and Isolation
Isolation of Leptospira from blood, urine, or tissue is definitive but technically demanding. The organism grows slowly in specialized media such as Ellinghausen-McCullough-Johnson-Harris (EMJH) medium and may take weeks to months. Culture is rarely used for clinical decision-making but remains important for epidemiological surveillance and genomic characterization [10].
Point-of-Care Testing
Rapid immunochromatographic tests (ICTs) for leptospirosis are available but generally have lower sensitivity than MAT or PCR. They are most useful in resource-limited settings or as screening tools. The performance of ICTs varies by serovar prevalence and disease stage.
Diagnostic Algorithm
The following Mermaid diagram outlines a recommended diagnostic workflow for a dog with suspected leptospirosis.
flowchart TD
A[Clinical suspicion: fever, azotemia, icterus, thrombocytopenia], > B{Acute phase < 10 days?}
B, >|Yes| C[Blood qPCR + MAT acute titer]
B, >|No| D[Urine qPCR + MAT acute titer]
C, > E{Positive qPCR or MAT >= 1:800?}
D, > E
E, >|Yes| F[Diagnosis confirmed: initiate treatment]
E, >|No| G[Repeat MAT in 2-4 weeks]
G, > H{Four-fold rise?}
H, >|Yes| F
H, >|No| I[Consider alternative diagnosis]
Treatment
Antimicrobial therapy aims to eliminate the spirochete from blood and tissues and to reduce renal shedding. Doxycycline is the drug of choice for canine leptospirosis. It is administered at 5 mg/kg orally every 12 hours or 10 mg/kg orally every 24 hours for 14 days. Doxycycline achieves high intracellular concentrations and is effective against both the leptospiremic and renal carrier phases. For dogs unable to tolerate oral medication, intravenous doxycycline hyclate can be used, although extravasation causes tissue necrosis. Alternative antimicrobials include amoxicillin (20 mg/kg every 8 hours) or ampicillin (20 mg/kg every 6 hours), but these do not eliminate renal carriage and should be followed by a course of doxycycline.
Supportive care is essential. Intravenous fluid therapy corrects dehydration and maintains renal perfusion. Dogs with acute kidney injury may require diuresis with balanced crystalloids. In oliguric or anuric patients, renal replacement therapy (hemodialysis or peritoneal dialysis) may be indicated. Hepatoprotective measures include administration of S-adenosylmethionine and vitamin E. Pulmonary hemorrhage requires oxygen supplementation and, in severe cases, mechanical ventilation. Blood transfusion may be necessary for coagulopathy or severe anemia.
Prevention
Vaccination
Vaccination is the cornerstone of leptospirosis prevention in dogs. Commercially available bacterin vaccines contain inactivated whole-cell antigens of the most prevalent serovars. Traditional vaccines included serovars Canicola and Icterohaemorrhagiae, but modern quadrivalent vaccines also include Grippotyphosa and Pomona. Some vaccines now incorporate serovar Australis. Vaccination does not prevent infection but reduces disease severity and renal shedding. The initial vaccination series requires two doses administered 2 to 4 weeks apart, followed by annual boosters. In high-risk areas, some authorities recommend booster vaccination every 6 months.
Vaccine efficacy is serovar-specific and wanes over time. Breakthrough infections can occur, particularly with serovars not included in the vaccine. A study of an outbreak in Los Angeles County identified serovars Icterohaemorrhagiae and Pomona as predominant, with many cases occurring in vaccinated dogs, highlighting the need for ongoing surveillance and vaccine strain matching [3].
Environmental and Behavioral Measures
Reducing exposure to contaminated water and wildlife urine is critical. Owners should prevent dogs from drinking from stagnant ponds, puddles, or streams. Rodent control around the home and kennel reduces the reservoir population. In kennel settings, disinfection with bleach or quaternary ammonium compounds is effective against leptospires. Dogs with confirmed leptospirosis should be isolated from other animals, and urine-contaminated areas should be cleaned with disinfectant.
Risk Factors and Epidemiology
Epidemiological studies have identified several risk factors for canine leptospirosis. A systematic review and meta-analysis of canine leptospirosis in China found that male dogs, intact dogs, and dogs living in rural or peri-urban areas had higher seroprevalence [6]. Meteorological factors, including rainfall and temperature, influence leptospiral survival in the environment and correlate with infection incidence in dog populations [2]. A study in subtropical Mexico reported seroprevalence rates exceeding 30% in stray dogs, underscoring the role of free-roaming populations as reservoirs [15]. In Colombia, molecular surveillance detected pathogenic Leptospira in domestic dogs, with L. interrogans serovar Icterohaemorrhagiae being the most common [11]. A One Health approach integrating human, animal, and environmental surveillance is essential for understanding transmission dynamics [5, 7].
Conclusion
Canine leptospirosis remains a diagnostic and therapeutic challenge due to its variable clinical presentation and the limitations of current diagnostic tests. The microscopic agglutination test remains the serological gold standard, but PCR offers earlier detection and species-level identification. Doxycycline is the preferred antimicrobial, and vaccination with multivalent bacterins reduces disease burden. Ongoing genomic surveillance and the development of improved recombinant antigen-based diagnostics will enhance our ability to control this zoonotic disease. Clinicians should maintain a high index of suspicion in dogs with acute febrile illness, particularly those with renal or hepatic involvement, and implement appropriate biosecurity measures to protect both animal and public health.
References
Bringold C, Schweighauser A, Walther S, et al. Serial evaluation of clinical, functional, and structural pulmonary changes in 10 dogs with leptospirosis. J Vet Intern Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42224492/
Hobson SJ, Zai B, Vyn CM, et al. Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211529/
Randolph MW, Nally JE, Yoshimoto SK, et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42189535/
Yaghoobpour T, Faraji M, Nazifi S. Serum Sialic Acid as a Biomarker of Inflammation and Infection: Insights From Veterinary Medicine. Vet Med Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42148179/
Patiño-Gómez S, Naranjo-Vargas LF, Aguirre-Acevedo DC, et al. Epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia: A One Health approach. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42090421/
Wei W, Jiao D, Dong X, et al. Epidemiology and associated factors of human and canine leptospirosis in China: a systematic review and meta-analysis. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864068/
Galvão CMMQ, Leite DPSBM, Oliveira PRF, et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41849483/
Skinner VJ, Ward MP, Griebsch C. Risk of infection in dogs in contact with clinical canine leptospirosis cases. Aust Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41814781/
Thongdee M, Chaiwattanarungruengpaisan S, Paungpin W, et al. Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41637464/
Kakita T, Takabe K, Morita M, et al. Genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild and feral animals in Japan. Int J Med Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41579465/
Beltrán-Sánchez CA, Bettin AC, Castellanos-Romero K, et al. Molecular surveillance of Leptospira infection in domestic dogs in Soledad, Northern Colombia. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41557245/
Gautam H, Kumar BVS, Singh S, et al. Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41524783/
Ding Y, Zhang S, Zhang W, et al. Seroprevalence and Molecular Epidemiology of Leptospira spp. Infecting Dogs in the Yangtze River Region of China. Transbound Emerg Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41383393/
Jost HE, Henriksen ML, Hawley J, et al. Evaluation of Leptospira species as a cause of endogenous uveitis in cats: a pilot study. J Feline Med Surg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41378760/
Andrade-Silveira E, Segura-Correa JC, Ortega-Pacheco A, et al. Seroprevalence of pathogenic leptospira in domiciled and stray dogs from subtropical Mexico. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41359150/